Pixcelldata signs an Australian Reseller Agreement with Perfekt Pty Ltd for digital pathology

Top Quote Pixcelldata and Perfekt announce an agreement to sell Collibio software for digital pathology collaboration into the Australian market. End Quote
  • (1888PressRelease) March 12, 2013 - Pixcelldata announces that Perfekt will offer Pixcelldata's leading Digital Pathology collaboration product, Collibio, into the Australian market. Perfekt has an excellent foothold in the Australian marketplace, and already sells the storage platforms into which Collibio is integrated.

    This new agreement means that Australian healthcare institutions will benefit from the world-leading open collaboration solution for digital pathology provided by a long-standing solution integrator with local representation and expertise that will bring many advantages to Australian pathology clinics and hospitals.

    Collibio software is an advanced and innovative web application for managing digital pathology images and associated data. It is designed to allow pathologists to immediately collaborate using images from proprietary scanner systems, and breaks down barriers for adoption of digital pathology.

    "Pixcelldata sees that Perfekt has the right mix of end user and underlying infrastructure skills that will allow Collibio to be deployed into a wide range of institutions in Australia", said Pixcelldata CEO, Alan Hanley. "Our product is successfully being used around the globe and we value partners like Perfekt who can help us to ensure our clients gain the vast improvements available through modern digital imaging solutions".

    Perfekt Director, Mark Sakajiou, comments "Our 10-year partnership in the storage technology used by Collibio has allowed Perfekt to extend the support we offer clients in industrial, education, government and now, right through to health care, through this new agreement. We are very optimistic about Collibio as we believe that the right solutions are now in place to allow complete end-to-end digital pathology deployments".

    For more information, please visit

  • FB Icon Twitter Icon In-Icon
Contact Information